HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful Heart Transplantation for Unreversible Endomyocardial Fibrosis Related to FIP1L1-PDGFRA Chronic Eosinophilic Leukemia.

AuthorsFanny Fassnacht, Mathilde Roumier, Pierre Fouret, Vincent Levy, Shaida Varnous, Stéphanie Russel, Guillaume Lefevre, Jean Emmanuel Kahn
JournalTransplantation (Transplantation) Vol. 99 Issue 11 Pg. e176-7 (Nov 2015) ISSN: 1534-6080 [Electronic] United States
PMID26492057 (Publication Type: Case Reports, Letter)
Chemical References
  • Antineoplastic Agents
  • Oncogene Proteins, Fusion
  • Protein Kinase Inhibitors
  • mRNA Cleavage and Polyadenylation Factors
  • Imatinib Mesylate
  • FIP1L1-PDGFRA fusion protein, human
  • Receptor, Platelet-Derived Growth Factor alpha
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Biopsy
  • Cardiomyopathies (diagnosis, etiology, surgery)
  • Fibrosis
  • Heart Transplantation
  • Humans
  • Hypereosinophilic Syndrome (complications, diagnosis, drug therapy, genetics)
  • Imatinib Mesylate (therapeutic use)
  • Leukemia
  • Magnetic Resonance Imaging
  • Male
  • Myocardium (pathology)
  • Oncogene Proteins, Fusion (genetics)
  • Protein Kinase Inhibitors (therapeutic use)
  • Receptor, Platelet-Derived Growth Factor alpha (genetics)
  • Treatment Outcome
  • mRNA Cleavage and Polyadenylation Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: